Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Equity Ratio (2016 - 2017)

Tenax Therapeutics' Equity Ratio history spans 6 years, with the latest figure at 0.92 for Q3 2017.

  • For Q3 2017, Equity Ratio rose 18.14% year-over-year to 0.92; the TTM value through Sep 2017 reached 0.92, up 18.14%, while the annual FY2016 figure was 0.73, N/A changed from the prior year.
  • Equity Ratio for Q3 2017 was 0.92 at Tenax Therapeutics, up from 0.84 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.92 in Q3 2017 and bottomed at 0.53 in Q1 2013.
  • The 4-year median for Equity Ratio is 0.79 (2016), against an average of 0.64.
  • The largest annual shift saw Equity Ratio plummeted 255.54% in 2013 before it rose 18.14% in 2017.
  • A 4-year view of Equity Ratio shows it stood at 0.53 in 2013, then skyrocketed by 257.38% to 0.83 in 2015, then dropped by 11.29% to 0.73 in 2016, then grew by 25.79% to 0.92 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Equity Ratio are 0.92 (Q3 2017), 0.84 (Q2 2017), and 0.74 (Q1 2017).